Roche’s live audio webcast and conference call post ASH 2017


Roche Hematology Portfolio: ASH update

Sandra Horning, M.D., Executive V.P., Chief Medical Officer and Head Global Product Development

Hemlibra development program overview: updated data in Hemophilia A patients with inhibitors

Gallia Levy, M.D., Ph.D, Global Development Team Leader, Hemlibra

Cristin Hubbard, Lifecycle Leader, Hemlibra

Link to on demand audio webcast